Preliminary exploration of amide proton transfer weighted imaging in differentiation between benign and malignant bone tumors

被引:0
|
作者
Li, Ying [1 ]
Lin, Liangjie [2 ]
Zhang, Yong [1 ]
Ren, Cuiping [1 ]
Zhang, Wenhua [1 ]
Cheng, Jingliang [1 ]
机构
[1] Zhengzhou Univ, Dept Magnet Resonance Imaging, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Philips Healthcare, Clin & Tech Support, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
bone tumor; amide proton transfer weighted imaging; diffusion weighted imaging; differential diagnosis; magnetic resonance imaging; SKELETAL LESIONS; MRI;
D O I
10.3389/fonc.2024.1402628
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To explore the value of 3D amide proton transfer weighted imaging (APTWI) in the differential diagnosis between benign and malignant bone tumors, and to compare the diagnostic performance of APTWI with traditional diffusion-weighted imaging (DWI). Materials and methods Patients with bone tumors located in the pelvis or lower limbs confirmed by puncture or surgical pathology were collected from January 2021 to July 2023 in the First Affiliated Hospital of Zhengzhou University. All patients underwent APTWI and DWI examinations. The magnetization transfer ratio with asymmetric analysis at the frequency offset of 3.5 ppm [MTRasym(3.5 ppm)] derived by APTWI and the apparent diffusion coefficient (ADC) derived by DWI for the tumors were measured. The Kolmogorou-Smirnou and Levene normality test was used to confirm the normal distribution of imaging parameters; and the independent sample t test was used to compare the differences in MTRasym(3.5 ppm) and ADC between benign and malignant bone tumors. In addition, the receiver operating characteristic (ROC) curve was used to evaluate the diagnostic performance of different imaging parameters in differentiation between benign and malignant bone tumors. P<0.05 means statistically significant. Results Among 85 bone tumor patients, 33 were benign and 52 were malignant. The MTRasym(3.5 ppm) values of malignant bone tumors were significantly higher than those of benign tumors, while the ADC values were significantly lower in benign tumors. ROC analysis shows that MTRasym(3.5 ppm) and ADC values perform well in the differential diagnosis of benign and malignant bone tumors, with the area under the ROC curve (AUC) of 0.798 and 0.780, respectively. Combination of MTRasym(3.5 ppm) and ADC values can further improve the diagnostic performance with the AUC of 0.849 (sensitivity = 84.9% and specificity = 73.1%). Conclusion MTRasym(3.5 ppm) of malignant bone tumors was significantly higher than that of benign bone tumors, reflecting the abnormal increase of protein synthesis in malignant tumors. APTWI combined with DWI can achieve a high diagnostic efficacy in differentiation between benign and malignant bone tumors.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Differentiation of Malignant and Benign Head and Neck Tumors with Amide Proton Transfer-Weighted MR Imaging
    Yu, Lu
    Li, Chunmei
    Luo, Xiaojie
    Zhou, Jinyuan
    Zhang, Chen
    Zhang, Yi
    Chen, Min
    MOLECULAR IMAGING AND BIOLOGY, 2019, 21 (02) : 348 - 355
  • [2] Differentiation of Malignant and Benign Head and Neck Tumors with Amide Proton Transfer-Weighted MR Imaging
    Lu Yu
    Chunmei Li
    Xiaojie Luo
    Jinyuan Zhou
    Chen Zhang
    Yi Zhang
    Min Chen
    Molecular Imaging and Biology, 2019, 21 : 348 - 355
  • [3] Amide proton transfer (APT) imaging of parotid tumors: Differentiation of malignant and benign tumors
    Kamitani, Takeshi
    Sagiyama, Koji
    Togao, Osamu
    Yamasaki, Yuzo
    Hida, Tomoyuki
    Matsuura, Yuko
    Murayama, Yuriko
    Yasumatsu, Ryuji
    Yamamoto, Hidetaka
    Yabuuchi, Hidetake
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 129
  • [4] Correction to: Differentiation of Malignant and Benign Head and Neck Tumors with Amide Proton Transfer-Weighted MR Imaging
    Lu Yu
    Chunmei Li
    Xiaojie Luo
    Jinyuan Zhou
    Chen Zhang
    Yi Zhang
    Min Chen
    Molecular Imaging and Biology, 2020, 22 : 218 - 218
  • [5] Differentiation of Malignant and Benign Head and Neck Tumors with Amide Proton Transfer-Weighted MR Imaging (vol 21, pg 348, 2019)
    Yu, Lu
    Li, Chunmei
    Luo, Xiaojie
    Zhou, Jinyuan
    Zhang, Chen
    Zhang, Yi
    Chen, Min
    MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (01) : 218 - 218
  • [6] Amide proton transfer imaging for differentiation of benign and atypical meningiomas
    Bio Joo
    Kyunghwa Han
    Yoon Seong Choi
    Seung-Koo Lee
    Sung Soo Ahn
    Jong Hee Chang
    Seok-Gu Kang
    Se Hoon Kim
    Jinyuan Zhou
    European Radiology, 2018, 28 : 331 - 339
  • [7] Amide proton transfer imaging for differentiation of benign and atypical meningiomas
    Joo, Bio
    Han, Kyunghwa
    Choi, Yoon Seong
    Lee, Seung-Koo
    Ahn, Sung Soo
    Chang, Jong Hee
    Kang, Seok-Gu
    Kim, Se Hoon
    Zhou, Jinyuan
    EUROPEAN RADIOLOGY, 2018, 28 (01) : 331 - 339
  • [8] Amide proton transfer-weighted magnetic resonance imaging for the differentiation of parotid gland tumors
    Wang, Yihua
    Wang, Lijun
    Huang, Haitao
    Ma, Juntao
    Lin, Liangjie
    Liu, Lin
    Song, Qingwei
    Liu, Ailian
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Diffusion-weighted imaging of breast tumors: Differentiation of benign and malignant tumors
    Gouhar, Ghada K.
    Zidan, El-Sayed H.
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2011, 42 (01): : 93 - 99
  • [10] Differentiation of fibroadenomas versus malignant breast tumors utilizing three-dimensional amide proton transfer weighted magnetic resonance imaging
    Zhang, Nan
    Kang, Jianyun
    Wang, Huali
    Liu, Ailian
    Miao, Yanwei
    Ma, Xiaolu
    Song, Qingwei
    Zhang, Lina
    Wang, Jiazheng
    Shen, Zhiwei
    Xu, Xiaofang
    CLINICAL IMAGING, 2022, 81 : 15 - 23